XERS short interest
Xeris Biopharma Holdings Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,202,379 |
|---|---|
| Change vs prior report | -856,598 (-10.6%) |
| Change over six months | -56.1% |
| Days to cover | 1.74 (sector: 3.78) |
| Average daily volume | 4,146,096 |
| Rank in Healthcare | #724 of 922 by days to cover |
XERS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,202,379 | -10.6% | 1.74 | 4,146,096 |
| 2026-09-15 | 8,058,977 | +0.2% | 4.83 | 1,667,316 |
| 2026-08-31 | 8,041,258 | -7.9% | 5.47 | 1,471,149 |
| 2026-08-14 | 8,728,856 | -5.3% | 4.44 | 1,965,890 |
| 2026-07-31 | 9,221,405 | -8.5% | 6.75 | 1,366,174 |
| 2026-07-15 | 10,078,469 | -21.0% | 4.38 | 2,299,463 |
| 2026-06-30 | 12,760,034 | -0.4% | 5.44 | 2,343,847 |
| 2026-06-15 | 12,810,046 | +2.4% | 7.33 | 1,746,604 |
| 2026-05-29 | 12,514,253 | +1.2% | 9.42 | 1,328,898 |
| 2026-05-15 | 12,364,664 | -22.2% | 5.80 | 2,131,991 |
| 2026-04-30 | 15,894,656 | +1.0% | 12.68 | 1,253,626 |
| 2026-04-15 | 15,738,746 | -4.1% | 11.01 | 1,429,569 |
| 2026-03-31 | 16,412,903 | +1.2% | 8.94 | 1,835,043 |
| 2026-03-13 | 16,223,073 | -4.7% | 6.77 | 2,396,368 |
| 2026-02-27 | 17,015,319 | -2.1% | 7.47 | 2,277,410 |
| 2026-02-13 | 17,385,964 | +2.3% | 13.89 | 1,252,005 |
| 2026-01-30 | 16,996,095 | +0.7% | 11.51 | 1,476,763 |
| 2026-01-15 | 16,883,379 | +2.2% | 6.04 | 2,796,279 |
| 2025-12-31 | 16,522,754 | +7.0% | 7.75 | 2,132,434 |
| 2025-12-15 | 15,434,811 | -3.4% | 6.93 | 2,228,593 |
| 2025-11-28 | 15,974,039 | +1.4% | 8.98 | 1,777,937 |
| 2025-11-14 | 15,746,194 | -10.7% | 4.01 | 3,924,309 |
| 2025-10-31 | 17,626,897 | -1.2% | 8.61 | 2,048,398 |
| 2025-10-15 | 17,850,615 | +2.4% | 7.69 | 2,321,770 |
| 2025-09-30 | 17,441,089 | +7.4% | 7.49 | 2,328,723 |
import finzdata as yf
yf.Ticker("XERS").short_interest # every report since 2017
yf.Client().short_interest(["XERS"], start="2018-01-01")Healthcare short interest · XERS price history · Who owns XERS · All short interest